Advanced biomarker and bioanalytical solutions

- Genomics (NGS, ctDNA, RNA-seq)
- Immunophenotyping (flow cytometry, IHC)
- Multiplex immunoassays, anatomic pathology and spatial biology

Explore how we work with pharma, biotech, medtech, government, and CROs to accelerate therapeutic development.
Our sector expertise spans a wide range of therapeutic areas and research models, backed by a global network of central and specialty laboratories.
Whether you’re navigating regulatory complexity, scaling precision medicine, or driving diagnostic innovation, our teams deliver evidence‑based laboratory solutions aligned to the needs of your study.

We combine scientific rigor with global reach, delivering laboratory solutions that are tailored, reliable, and scalable across every stage of drug development.




Explore an overview of our global laboratory capabilities and scientific expertise, designed to support clinical research across all phases of development. This brochure highlights our end-to-end specialty lab solutions, from biomarker strategy and assay development to global logistics and data delivery, helping you accelerate discovery and bring innovative therapies to patients faster.

Cell and gene therapies are transforming the treatment landscape, but their clinical development presents unique operational and logistical challenges, particularly in rare diseases. This whitepaper explores the complexities of supporting CGT trials, from decentralized patient populations to the need for flexible, specialized logistics networks.

There are important questions you need to ask yourself and any potential laboratory partner before you start a study, including PBMC assays as part of your protocol. In this brochure, we break down these questions and the key considerations to make to ensure sample integrity at every stage.
